Showing results (361-370 of 408) with videos related to

Sort By:
Pageof 41
Ophthalmology. Retina|May 4, 2019
Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: VIEW 1 Extension StudyPeter K Kaiser, Michael Singer, Michael Tolentino, et al.
JAMA Ophthalmology|November 24, 2021
Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare MapArshad M Khanani, Marco A Zarbin, Mark R Barakat, et al.
American Journal of Ophthalmology|March 19, 2013
16 and 24 Gy low-voltage X-ray irradiation with ranibizumab therapy for neovascular age-related macular degeneration: 12-month outcomesVirgilio Morales-Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
The British Journal of Ophthalmology|August 17, 2012
16 Gy low-voltage x-ray irradiation followed by as needed ranibizumab therapy for age-related macular degeneration: 12 month outcomes of a 'radiation-first' strategyAndrew A Moshfeghi, Virgilio Morales-Canton, Hugo Quiroz-Mercado, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|January 19, 2012
24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomesVirgilio Morales Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
Pageof 41